Review



primers probes ddpcr reference housekeeping gene (rpp30  (Bio-Rad)


Bioz Verified Symbol Bio-Rad is a verified supplier  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 90

    Structured Review

    Bio-Rad primers probes ddpcr reference housekeeping gene (rpp30
    Organoid generation retains clinically relevant tumor genomic heterogeneity. (A) Copy number amplified genes in IDC patients found in distant organ metastasis, unspecified metastasis site, or lymph node metastasis compared to primary breast cancer samples in the GENIE database. Of the genes (dots) amplified in greater than 10% of primary or metastatic samples, the top 10 statistically significant (blue dots) differentially amplified in metastatic samples are circled. These include ADGRA2, RAD21, PAK1, FGF4, NSD3, FGF19, FGF3, CCND1, FGFR1, and MYC. (B) Schema of workflow for sample generation. Large primary mammary tumors are dissected from the fat pad. Tissue segments are excised from 4 distinct regions of the tumor to ensure adequate sampling. Organoids generated from the tumors were sampled and dissociated and strained to single cells, taken as pooled organoid samples, or isolated to single organoids. All samples were then used to isolate gDNA and perform <t>ddPCR.</t> (C) FGFR1 copy numbers in tissue, pooled organoids (Org), and single cell digests (Digest) from two different mice normalized to the housekeeping <t>gene</t> <t>RPP30.</t> Tissue sample copy number alterations are statistically different than pooled organoid samples (Mann-Whitney, p < 0.05). Each point represents separate batches of organoids generated from primary tumor ( n = 2, r = 2). Each primary tumor was split into 4 samples for separate organoid generation to ensure adequate sampling over the whole tumor. (D) FGFR1 copy numbers in single organoids from tumors from two different mice. Among each tumor there exist statistically distinct copy numbers (Kruskall-Wallis, p = 0.0222; p = 0.0032).
    Primers Probes Ddpcr Reference Housekeeping Gene (Rpp30, supplied by Bio-Rad, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/rpp30+primers/pmc11140600-104-4-20?v=Bio-Rad
    Average 90 stars, based on 1 article reviews
    primers probes ddpcr reference housekeeping gene (rpp30 - by Bioz Stars, 2026-07
    90/100 stars

    Images

    1) Product Images from "Digital droplet PCR analysis of organoids generated from mouse mammary tumors demonstrates proof-of-concept capture of tumor heterogeneity"

    Article Title: Digital droplet PCR analysis of organoids generated from mouse mammary tumors demonstrates proof-of-concept capture of tumor heterogeneity

    Journal: Frontiers in Cell and Developmental Biology

    doi: 10.3389/fcell.2024.1358583

    Organoid generation retains clinically relevant tumor genomic heterogeneity. (A) Copy number amplified genes in IDC patients found in distant organ metastasis, unspecified metastasis site, or lymph node metastasis compared to primary breast cancer samples in the GENIE database. Of the genes (dots) amplified in greater than 10% of primary or metastatic samples, the top 10 statistically significant (blue dots) differentially amplified in metastatic samples are circled. These include ADGRA2, RAD21, PAK1, FGF4, NSD3, FGF19, FGF3, CCND1, FGFR1, and MYC. (B) Schema of workflow for sample generation. Large primary mammary tumors are dissected from the fat pad. Tissue segments are excised from 4 distinct regions of the tumor to ensure adequate sampling. Organoids generated from the tumors were sampled and dissociated and strained to single cells, taken as pooled organoid samples, or isolated to single organoids. All samples were then used to isolate gDNA and perform ddPCR. (C) FGFR1 copy numbers in tissue, pooled organoids (Org), and single cell digests (Digest) from two different mice normalized to the housekeeping gene RPP30. Tissue sample copy number alterations are statistically different than pooled organoid samples (Mann-Whitney, p < 0.05). Each point represents separate batches of organoids generated from primary tumor ( n = 2, r = 2). Each primary tumor was split into 4 samples for separate organoid generation to ensure adequate sampling over the whole tumor. (D) FGFR1 copy numbers in single organoids from tumors from two different mice. Among each tumor there exist statistically distinct copy numbers (Kruskall-Wallis, p = 0.0222; p = 0.0032).
    Figure Legend Snippet: Organoid generation retains clinically relevant tumor genomic heterogeneity. (A) Copy number amplified genes in IDC patients found in distant organ metastasis, unspecified metastasis site, or lymph node metastasis compared to primary breast cancer samples in the GENIE database. Of the genes (dots) amplified in greater than 10% of primary or metastatic samples, the top 10 statistically significant (blue dots) differentially amplified in metastatic samples are circled. These include ADGRA2, RAD21, PAK1, FGF4, NSD3, FGF19, FGF3, CCND1, FGFR1, and MYC. (B) Schema of workflow for sample generation. Large primary mammary tumors are dissected from the fat pad. Tissue segments are excised from 4 distinct regions of the tumor to ensure adequate sampling. Organoids generated from the tumors were sampled and dissociated and strained to single cells, taken as pooled organoid samples, or isolated to single organoids. All samples were then used to isolate gDNA and perform ddPCR. (C) FGFR1 copy numbers in tissue, pooled organoids (Org), and single cell digests (Digest) from two different mice normalized to the housekeeping gene RPP30. Tissue sample copy number alterations are statistically different than pooled organoid samples (Mann-Whitney, p < 0.05). Each point represents separate batches of organoids generated from primary tumor ( n = 2, r = 2). Each primary tumor was split into 4 samples for separate organoid generation to ensure adequate sampling over the whole tumor. (D) FGFR1 copy numbers in single organoids from tumors from two different mice. Among each tumor there exist statistically distinct copy numbers (Kruskall-Wallis, p = 0.0222; p = 0.0032).

    Techniques Used: Amplification, Sampling, Generated, Isolation, MANN-WHITNEY

    FGFR1 is copy number amplified in both human metastasis and in vitro model of metastasis. (A) Representative image of a non-invading, control group organoid in liquid media (top). Representative image of an invading, experimental group organoid post-collagenase digestion in liquid media (bottom). Both of these organoids were initially allowed to grow either in media (control) or type-1 collagen ECM (experimental) for 48 h. These images are representative of the conditions assessed in this figure (B) . (B) FGFR1 copy number is amplified in invading organoids vs. control organoids from PyMT mouse primary mammary tumor samples (Mann-Whitney, p = 0.0022). Each point represents copy number measured from duplicate control or invasive organoid samples from 2 PyMT mouse primary mammary tumor organoids. Duplicates were performed for each sample in ddPCR. Duplicates were not included for those >20% apart.
    Figure Legend Snippet: FGFR1 is copy number amplified in both human metastasis and in vitro model of metastasis. (A) Representative image of a non-invading, control group organoid in liquid media (top). Representative image of an invading, experimental group organoid post-collagenase digestion in liquid media (bottom). Both of these organoids were initially allowed to grow either in media (control) or type-1 collagen ECM (experimental) for 48 h. These images are representative of the conditions assessed in this figure (B) . (B) FGFR1 copy number is amplified in invading organoids vs. control organoids from PyMT mouse primary mammary tumor samples (Mann-Whitney, p = 0.0022). Each point represents copy number measured from duplicate control or invasive organoid samples from 2 PyMT mouse primary mammary tumor organoids. Duplicates were performed for each sample in ddPCR. Duplicates were not included for those >20% apart.

    Techniques Used: Amplification, In Vitro, MANN-WHITNEY



    Similar Products

    91
    Addgene inc n a rhesus rpp30 forward primer gacttggacgtgcgagcg singh
    N A Rhesus Rpp30 Forward Primer Gacttggacgtgcgagcg Singh, supplied by Addgene inc, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/rpp30+primers/pmc11228584__mmc2-185-46-78?v=Addgene+inc
    Average 91 stars, based on 1 article reviews
    n a rhesus rpp30 forward primer gacttggacgtgcgagcg singh - by Bioz Stars, 2026-07
    91/100 stars
      Buy from Supplier

    91
    Addgene inc n a rhesus rpp30 reverse primer gccgctgtctccacaagt singh
    N A Rhesus Rpp30 Reverse Primer Gccgctgtctccacaagt Singh, supplied by Addgene inc, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/rpp30+primers/pmc11228584__mmc2-185-55-78?v=Addgene+inc
    Average 91 stars, based on 1 article reviews
    n a rhesus rpp30 reverse primer gccgctgtctccacaagt singh - by Bioz Stars, 2026-07
    91/100 stars
      Buy from Supplier

    90
    Bio-Rad primers probes ddpcr reference housekeeping gene (rpp30
    Organoid generation retains clinically relevant tumor genomic heterogeneity. (A) Copy number amplified genes in IDC patients found in distant organ metastasis, unspecified metastasis site, or lymph node metastasis compared to primary breast cancer samples in the GENIE database. Of the genes (dots) amplified in greater than 10% of primary or metastatic samples, the top 10 statistically significant (blue dots) differentially amplified in metastatic samples are circled. These include ADGRA2, RAD21, PAK1, FGF4, NSD3, FGF19, FGF3, CCND1, FGFR1, and MYC. (B) Schema of workflow for sample generation. Large primary mammary tumors are dissected from the fat pad. Tissue segments are excised from 4 distinct regions of the tumor to ensure adequate sampling. Organoids generated from the tumors were sampled and dissociated and strained to single cells, taken as pooled organoid samples, or isolated to single organoids. All samples were then used to isolate gDNA and perform <t>ddPCR.</t> (C) FGFR1 copy numbers in tissue, pooled organoids (Org), and single cell digests (Digest) from two different mice normalized to the housekeeping <t>gene</t> <t>RPP30.</t> Tissue sample copy number alterations are statistically different than pooled organoid samples (Mann-Whitney, p < 0.05). Each point represents separate batches of organoids generated from primary tumor ( n = 2, r = 2). Each primary tumor was split into 4 samples for separate organoid generation to ensure adequate sampling over the whole tumor. (D) FGFR1 copy numbers in single organoids from tumors from two different mice. Among each tumor there exist statistically distinct copy numbers (Kruskall-Wallis, p = 0.0222; p = 0.0032).
    Primers Probes Ddpcr Reference Housekeeping Gene (Rpp30, supplied by Bio-Rad, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/rpp30+primers/pmc11140600-104-4-20?v=Bio-Rad
    Average 90 stars, based on 1 article reviews
    primers probes ddpcr reference housekeeping gene (rpp30 - by Bioz Stars, 2026-07
    90/100 stars
      Buy from Supplier

    90
    Bio-Rad primers/probes detect human rpp30
    Organoid generation retains clinically relevant tumor genomic heterogeneity. (A) Copy number amplified genes in IDC patients found in distant organ metastasis, unspecified metastasis site, or lymph node metastasis compared to primary breast cancer samples in the GENIE database. Of the genes (dots) amplified in greater than 10% of primary or metastatic samples, the top 10 statistically significant (blue dots) differentially amplified in metastatic samples are circled. These include ADGRA2, RAD21, PAK1, FGF4, NSD3, FGF19, FGF3, CCND1, FGFR1, and MYC. (B) Schema of workflow for sample generation. Large primary mammary tumors are dissected from the fat pad. Tissue segments are excised from 4 distinct regions of the tumor to ensure adequate sampling. Organoids generated from the tumors were sampled and dissociated and strained to single cells, taken as pooled organoid samples, or isolated to single organoids. All samples were then used to isolate gDNA and perform <t>ddPCR.</t> (C) FGFR1 copy numbers in tissue, pooled organoids (Org), and single cell digests (Digest) from two different mice normalized to the housekeeping <t>gene</t> <t>RPP30.</t> Tissue sample copy number alterations are statistically different than pooled organoid samples (Mann-Whitney, p < 0.05). Each point represents separate batches of organoids generated from primary tumor ( n = 2, r = 2). Each primary tumor was split into 4 samples for separate organoid generation to ensure adequate sampling over the whole tumor. (D) FGFR1 copy numbers in single organoids from tumors from two different mice. Among each tumor there exist statistically distinct copy numbers (Kruskall-Wallis, p = 0.0222; p = 0.0032).
    Primers/Probes Detect Human Rpp30, supplied by Bio-Rad, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/rpp30+primers/bio_rxiv__2024__03__08__584099-234-3-5?v=Bio-Rad
    Average 90 stars, based on 1 article reviews
    primers/probes detect human rpp30 - by Bioz Stars, 2026-07
    90/100 stars
      Buy from Supplier

    86
    Danaher Inc rpp30 primers probe
    Organoid generation retains clinically relevant tumor genomic heterogeneity. (A) Copy number amplified genes in IDC patients found in distant organ metastasis, unspecified metastasis site, or lymph node metastasis compared to primary breast cancer samples in the GENIE database. Of the genes (dots) amplified in greater than 10% of primary or metastatic samples, the top 10 statistically significant (blue dots) differentially amplified in metastatic samples are circled. These include ADGRA2, RAD21, PAK1, FGF4, NSD3, FGF19, FGF3, CCND1, FGFR1, and MYC. (B) Schema of workflow for sample generation. Large primary mammary tumors are dissected from the fat pad. Tissue segments are excised from 4 distinct regions of the tumor to ensure adequate sampling. Organoids generated from the tumors were sampled and dissociated and strained to single cells, taken as pooled organoid samples, or isolated to single organoids. All samples were then used to isolate gDNA and perform <t>ddPCR.</t> (C) FGFR1 copy numbers in tissue, pooled organoids (Org), and single cell digests (Digest) from two different mice normalized to the housekeeping <t>gene</t> <t>RPP30.</t> Tissue sample copy number alterations are statistically different than pooled organoid samples (Mann-Whitney, p < 0.05). Each point represents separate batches of organoids generated from primary tumor ( n = 2, r = 2). Each primary tumor was split into 4 samples for separate organoid generation to ensure adequate sampling over the whole tumor. (D) FGFR1 copy numbers in single organoids from tumors from two different mice. Among each tumor there exist statistically distinct copy numbers (Kruskall-Wallis, p = 0.0222; p = 0.0032).
    Rpp30 Primers Probe, supplied by Danaher Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/rpp30+primers/pm37694295-60-27-31?v=Danaher+Inc
    Average 86 stars, based on 1 article reviews
    rpp30 primers probe - by Bioz Stars, 2026-07
    86/100 stars
      Buy from Supplier

    90
    GenScript corporation rpp30 primers
    Organoid generation retains clinically relevant tumor genomic heterogeneity. (A) Copy number amplified genes in IDC patients found in distant organ metastasis, unspecified metastasis site, or lymph node metastasis compared to primary breast cancer samples in the GENIE database. Of the genes (dots) amplified in greater than 10% of primary or metastatic samples, the top 10 statistically significant (blue dots) differentially amplified in metastatic samples are circled. These include ADGRA2, RAD21, PAK1, FGF4, NSD3, FGF19, FGF3, CCND1, FGFR1, and MYC. (B) Schema of workflow for sample generation. Large primary mammary tumors are dissected from the fat pad. Tissue segments are excised from 4 distinct regions of the tumor to ensure adequate sampling. Organoids generated from the tumors were sampled and dissociated and strained to single cells, taken as pooled organoid samples, or isolated to single organoids. All samples were then used to isolate gDNA and perform <t>ddPCR.</t> (C) FGFR1 copy numbers in tissue, pooled organoids (Org), and single cell digests (Digest) from two different mice normalized to the housekeeping <t>gene</t> <t>RPP30.</t> Tissue sample copy number alterations are statistically different than pooled organoid samples (Mann-Whitney, p < 0.05). Each point represents separate batches of organoids generated from primary tumor ( n = 2, r = 2). Each primary tumor was split into 4 samples for separate organoid generation to ensure adequate sampling over the whole tumor. (D) FGFR1 copy numbers in single organoids from tumors from two different mice. Among each tumor there exist statistically distinct copy numbers (Kruskall-Wallis, p = 0.0222; p = 0.0032).
    Rpp30 Primers, supplied by GenScript corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/rpp30+primers/us11697848-93-215-220?v=GenScript+corporation
    Average 90 stars, based on 1 article reviews
    rpp30 primers - by Bioz Stars, 2026-07
    90/100 stars
      Buy from Supplier

    86
    Danaher Inc rpp30 shear reverse primer catgcaaaggaggaagccg
    Organoid generation retains clinically relevant tumor genomic heterogeneity. (A) Copy number amplified genes in IDC patients found in distant organ metastasis, unspecified metastasis site, or lymph node metastasis compared to primary breast cancer samples in the GENIE database. Of the genes (dots) amplified in greater than 10% of primary or metastatic samples, the top 10 statistically significant (blue dots) differentially amplified in metastatic samples are circled. These include ADGRA2, RAD21, PAK1, FGF4, NSD3, FGF19, FGF3, CCND1, FGFR1, and MYC. (B) Schema of workflow for sample generation. Large primary mammary tumors are dissected from the fat pad. Tissue segments are excised from 4 distinct regions of the tumor to ensure adequate sampling. Organoids generated from the tumors were sampled and dissociated and strained to single cells, taken as pooled organoid samples, or isolated to single organoids. All samples were then used to isolate gDNA and perform <t>ddPCR.</t> (C) FGFR1 copy numbers in tissue, pooled organoids (Org), and single cell digests (Digest) from two different mice normalized to the housekeeping <t>gene</t> <t>RPP30.</t> Tissue sample copy number alterations are statistically different than pooled organoid samples (Mann-Whitney, p < 0.05). Each point represents separate batches of organoids generated from primary tumor ( n = 2, r = 2). Each primary tumor was split into 4 samples for separate organoid generation to ensure adequate sampling over the whole tumor. (D) FGFR1 copy numbers in single organoids from tumors from two different mice. Among each tumor there exist statistically distinct copy numbers (Kruskall-Wallis, p = 0.0222; p = 0.0032).
    Rpp30 Shear Reverse Primer Catgcaaaggaggaagccg, supplied by Danaher Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/rpp30+primers/pm37440871-43-90-105?v=Danaher+Inc
    Average 86 stars, based on 1 article reviews
    rpp30 shear reverse primer catgcaaaggaggaagccg - by Bioz Stars, 2026-07
    86/100 stars
      Buy from Supplier

    90
    Bio-Rad primers rpp30
    Organoid generation retains clinically relevant tumor genomic heterogeneity. (A) Copy number amplified genes in IDC patients found in distant organ metastasis, unspecified metastasis site, or lymph node metastasis compared to primary breast cancer samples in the GENIE database. Of the genes (dots) amplified in greater than 10% of primary or metastatic samples, the top 10 statistically significant (blue dots) differentially amplified in metastatic samples are circled. These include ADGRA2, RAD21, PAK1, FGF4, NSD3, FGF19, FGF3, CCND1, FGFR1, and MYC. (B) Schema of workflow for sample generation. Large primary mammary tumors are dissected from the fat pad. Tissue segments are excised from 4 distinct regions of the tumor to ensure adequate sampling. Organoids generated from the tumors were sampled and dissociated and strained to single cells, taken as pooled organoid samples, or isolated to single organoids. All samples were then used to isolate gDNA and perform <t>ddPCR.</t> (C) FGFR1 copy numbers in tissue, pooled organoids (Org), and single cell digests (Digest) from two different mice normalized to the housekeeping <t>gene</t> <t>RPP30.</t> Tissue sample copy number alterations are statistically different than pooled organoid samples (Mann-Whitney, p < 0.05). Each point represents separate batches of organoids generated from primary tumor ( n = 2, r = 2). Each primary tumor was split into 4 samples for separate organoid generation to ensure adequate sampling over the whole tumor. (D) FGFR1 copy numbers in single organoids from tumors from two different mice. Among each tumor there exist statistically distinct copy numbers (Kruskall-Wallis, p = 0.0222; p = 0.0032).
    Primers Rpp30, supplied by Bio-Rad, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/rpp30+primers/pmc10150239-176-5-0?v=Bio-Rad
    Average 90 stars, based on 1 article reviews
    primers rpp30 - by Bioz Stars, 2026-07
    90/100 stars
      Buy from Supplier

    85
    Bio-Rad rpp30 primers
    Organoid generation retains clinically relevant tumor genomic heterogeneity. (A) Copy number amplified genes in IDC patients found in distant organ metastasis, unspecified metastasis site, or lymph node metastasis compared to primary breast cancer samples in the GENIE database. Of the genes (dots) amplified in greater than 10% of primary or metastatic samples, the top 10 statistically significant (blue dots) differentially amplified in metastatic samples are circled. These include ADGRA2, RAD21, PAK1, FGF4, NSD3, FGF19, FGF3, CCND1, FGFR1, and MYC. (B) Schema of workflow for sample generation. Large primary mammary tumors are dissected from the fat pad. Tissue segments are excised from 4 distinct regions of the tumor to ensure adequate sampling. Organoids generated from the tumors were sampled and dissociated and strained to single cells, taken as pooled organoid samples, or isolated to single organoids. All samples were then used to isolate gDNA and perform <t>ddPCR.</t> (C) FGFR1 copy numbers in tissue, pooled organoids (Org), and single cell digests (Digest) from two different mice normalized to the housekeeping <t>gene</t> <t>RPP30.</t> Tissue sample copy number alterations are statistically different than pooled organoid samples (Mann-Whitney, p < 0.05). Each point represents separate batches of organoids generated from primary tumor ( n = 2, r = 2). Each primary tumor was split into 4 samples for separate organoid generation to ensure adequate sampling over the whole tumor. (D) FGFR1 copy numbers in single organoids from tumors from two different mice. Among each tumor there exist statistically distinct copy numbers (Kruskall-Wallis, p = 0.0222; p = 0.0032).
    Rpp30 Primers, supplied by Bio-Rad, used in various techniques. Bioz Stars score: 85/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/rpp30+primers/pm36625728-215-26-19?v=Bio-Rad
    Average 85 stars, based on 1 article reviews
    rpp30 primers - by Bioz Stars, 2026-07
    85/100 stars
      Buy from Supplier

    90
    Bio-Rad rpp30 primers/probe
    Organoid generation retains clinically relevant tumor genomic heterogeneity. (A) Copy number amplified genes in IDC patients found in distant organ metastasis, unspecified metastasis site, or lymph node metastasis compared to primary breast cancer samples in the GENIE database. Of the genes (dots) amplified in greater than 10% of primary or metastatic samples, the top 10 statistically significant (blue dots) differentially amplified in metastatic samples are circled. These include ADGRA2, RAD21, PAK1, FGF4, NSD3, FGF19, FGF3, CCND1, FGFR1, and MYC. (B) Schema of workflow for sample generation. Large primary mammary tumors are dissected from the fat pad. Tissue segments are excised from 4 distinct regions of the tumor to ensure adequate sampling. Organoids generated from the tumors were sampled and dissociated and strained to single cells, taken as pooled organoid samples, or isolated to single organoids. All samples were then used to isolate gDNA and perform <t>ddPCR.</t> (C) FGFR1 copy numbers in tissue, pooled organoids (Org), and single cell digests (Digest) from two different mice normalized to the housekeeping <t>gene</t> <t>RPP30.</t> Tissue sample copy number alterations are statistically different than pooled organoid samples (Mann-Whitney, p < 0.05). Each point represents separate batches of organoids generated from primary tumor ( n = 2, r = 2). Each primary tumor was split into 4 samples for separate organoid generation to ensure adequate sampling over the whole tumor. (D) FGFR1 copy numbers in single organoids from tumors from two different mice. Among each tumor there exist statistically distinct copy numbers (Kruskall-Wallis, p = 0.0222; p = 0.0032).
    Rpp30 Primers/Probe, supplied by Bio-Rad, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/rpp30+primers/pm36413407-246-38-40?v=Bio-Rad
    Average 90 stars, based on 1 article reviews
    rpp30 primers/probe - by Bioz Stars, 2026-07
    90/100 stars
      Buy from Supplier

    Image Search Results


    Organoid generation retains clinically relevant tumor genomic heterogeneity. (A) Copy number amplified genes in IDC patients found in distant organ metastasis, unspecified metastasis site, or lymph node metastasis compared to primary breast cancer samples in the GENIE database. Of the genes (dots) amplified in greater than 10% of primary or metastatic samples, the top 10 statistically significant (blue dots) differentially amplified in metastatic samples are circled. These include ADGRA2, RAD21, PAK1, FGF4, NSD3, FGF19, FGF3, CCND1, FGFR1, and MYC. (B) Schema of workflow for sample generation. Large primary mammary tumors are dissected from the fat pad. Tissue segments are excised from 4 distinct regions of the tumor to ensure adequate sampling. Organoids generated from the tumors were sampled and dissociated and strained to single cells, taken as pooled organoid samples, or isolated to single organoids. All samples were then used to isolate gDNA and perform ddPCR. (C) FGFR1 copy numbers in tissue, pooled organoids (Org), and single cell digests (Digest) from two different mice normalized to the housekeeping gene RPP30. Tissue sample copy number alterations are statistically different than pooled organoid samples (Mann-Whitney, p < 0.05). Each point represents separate batches of organoids generated from primary tumor ( n = 2, r = 2). Each primary tumor was split into 4 samples for separate organoid generation to ensure adequate sampling over the whole tumor. (D) FGFR1 copy numbers in single organoids from tumors from two different mice. Among each tumor there exist statistically distinct copy numbers (Kruskall-Wallis, p = 0.0222; p = 0.0032).

    Journal: Frontiers in Cell and Developmental Biology

    Article Title: Digital droplet PCR analysis of organoids generated from mouse mammary tumors demonstrates proof-of-concept capture of tumor heterogeneity

    doi: 10.3389/fcell.2024.1358583

    Figure Lengend Snippet: Organoid generation retains clinically relevant tumor genomic heterogeneity. (A) Copy number amplified genes in IDC patients found in distant organ metastasis, unspecified metastasis site, or lymph node metastasis compared to primary breast cancer samples in the GENIE database. Of the genes (dots) amplified in greater than 10% of primary or metastatic samples, the top 10 statistically significant (blue dots) differentially amplified in metastatic samples are circled. These include ADGRA2, RAD21, PAK1, FGF4, NSD3, FGF19, FGF3, CCND1, FGFR1, and MYC. (B) Schema of workflow for sample generation. Large primary mammary tumors are dissected from the fat pad. Tissue segments are excised from 4 distinct regions of the tumor to ensure adequate sampling. Organoids generated from the tumors were sampled and dissociated and strained to single cells, taken as pooled organoid samples, or isolated to single organoids. All samples were then used to isolate gDNA and perform ddPCR. (C) FGFR1 copy numbers in tissue, pooled organoids (Org), and single cell digests (Digest) from two different mice normalized to the housekeeping gene RPP30. Tissue sample copy number alterations are statistically different than pooled organoid samples (Mann-Whitney, p < 0.05). Each point represents separate batches of organoids generated from primary tumor ( n = 2, r = 2). Each primary tumor was split into 4 samples for separate organoid generation to ensure adequate sampling over the whole tumor. (D) FGFR1 copy numbers in single organoids from tumors from two different mice. Among each tumor there exist statistically distinct copy numbers (Kruskall-Wallis, p = 0.0222; p = 0.0032).

    Article Snippet: Primers and probes for ddPCR for reference housekeeping gene (RPP30) and target genes (ADGRA2, FGFR1, NSD3, PAK1) were purchased from Bio-Rad Laboratories (Assay IDs: dMmuCNS822293939, dMmuCNS263266645, dMmuCNS890129559, dMmuCNS681547140, dMmuCNS429051281, respectively).

    Techniques: Amplification, Sampling, Generated, Isolation, MANN-WHITNEY

    FGFR1 is copy number amplified in both human metastasis and in vitro model of metastasis. (A) Representative image of a non-invading, control group organoid in liquid media (top). Representative image of an invading, experimental group organoid post-collagenase digestion in liquid media (bottom). Both of these organoids were initially allowed to grow either in media (control) or type-1 collagen ECM (experimental) for 48 h. These images are representative of the conditions assessed in this figure (B) . (B) FGFR1 copy number is amplified in invading organoids vs. control organoids from PyMT mouse primary mammary tumor samples (Mann-Whitney, p = 0.0022). Each point represents copy number measured from duplicate control or invasive organoid samples from 2 PyMT mouse primary mammary tumor organoids. Duplicates were performed for each sample in ddPCR. Duplicates were not included for those >20% apart.

    Journal: Frontiers in Cell and Developmental Biology

    Article Title: Digital droplet PCR analysis of organoids generated from mouse mammary tumors demonstrates proof-of-concept capture of tumor heterogeneity

    doi: 10.3389/fcell.2024.1358583

    Figure Lengend Snippet: FGFR1 is copy number amplified in both human metastasis and in vitro model of metastasis. (A) Representative image of a non-invading, control group organoid in liquid media (top). Representative image of an invading, experimental group organoid post-collagenase digestion in liquid media (bottom). Both of these organoids were initially allowed to grow either in media (control) or type-1 collagen ECM (experimental) for 48 h. These images are representative of the conditions assessed in this figure (B) . (B) FGFR1 copy number is amplified in invading organoids vs. control organoids from PyMT mouse primary mammary tumor samples (Mann-Whitney, p = 0.0022). Each point represents copy number measured from duplicate control or invasive organoid samples from 2 PyMT mouse primary mammary tumor organoids. Duplicates were performed for each sample in ddPCR. Duplicates were not included for those >20% apart.

    Article Snippet: Primers and probes for ddPCR for reference housekeeping gene (RPP30) and target genes (ADGRA2, FGFR1, NSD3, PAK1) were purchased from Bio-Rad Laboratories (Assay IDs: dMmuCNS822293939, dMmuCNS263266645, dMmuCNS890129559, dMmuCNS681547140, dMmuCNS429051281, respectively).

    Techniques: Amplification, In Vitro, MANN-WHITNEY